NCNA
NuCana PLC
NASDAQ: NCNA · HEALTHCARE · BIOTECHNOLOGY
$2.13
+4.41% today
Updated 2026-04-30
Market cap
$9.20M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $250
Volume
0.0M
NuCana PLC (NCNA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $35675.00 | $31.68M | $27.21M | $96.36M | $87.19M | $70.27M | $107.79M | $77.47M | $58.25M | $27.81M | $14.77M |
| Cash & equivalents | $33761.00 | $14.11M | $19.99M | $86.70M | $76.97M | $51.96M | $87.36M | $60.26M | $41.91M | $17.23M | $6.75M |
| Current assets | $35086.00 | $30.74M | $25.82M | $93.98M | $83.59M | $65.15M | $101.81M | $71.61M | $54.92M | $25.02M | $12.27M |
| Total liabilities | $1167.00 | $1.73M | $1.97M | $2.94M | $5.59M | $6.75M | $8.56M | $11.93M | $19.75M | $12.92M | $8.82M |
| Current liabilities | $1167.00 | $1.73M | $1.97M | $2.92M | $5.57M | $6.18M | $8.15M | $11.72M | $19.31M | $12.68M | $8.67M |
| Long-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Shareholder equity | $34508.00 | $29.96M | $25.24M | $93.42M | $81.59M | $63.52M | $99.23M | $65.55M | $38.50M | $14.89M | $5.95M |
| Retained earnings | $-10892.00 | $-16.22M | $-22.26M | $-45.16M | $-58.81M | $-80.06M | $-110.59M | $-149.73M | $-180.57M | $-207.71M | $-224.29M |
| Accounts receivable | $1.67M | $1.50M | $2.61M | $7.28M | $6.62M | $13.19M | $14.45M | $11.35M | $50000.00 | $5.83M | $4.64M |
| Inventory | $0.00 | $-15.02M | $3.20M | $-3.05M | $-1.80M | $-13191.00 | $-14450.00 | $-11349.00 | — | — | — |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |